海王英特龍2013年報

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治療藥物和預防用生物制品，創(chuàng)建以自主知識產(chǎn)權(quán)產(chǎn)品研發(fā)和專業(yè)化營銷能力為代表的核心競爭力，逐步確立國內(nèi)市

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治

2020 A N N %5Cu A L REPO RT 2020 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a ma

2017 A N N %5Cu A L REPO RT 2017 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a ma

（於中華人民共和國註冊成立之股份有限公司） Stock Code 股份代號 : 8329 * For identification p%5Curpose only 僅供識別之用 年報 A N N %5Cu A L R EP O R T 2012 年 報 Breast Stem cells Creativity

ANN%5CuAL REPORT 年報 2023 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market des

2021 Ann%5Cual Report 年報 A N N %5Cu A L REPO RT 2021 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been p

A N N %5Cu A L REPO RT 2018 2018 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a ma

CHARACTERISTICS OF THE GROWTH ENTERPRISE MARKET (“GEM”) OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a

2022 ANN%5CuAL REPORT 年報 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market des